TAT 2019: Scientific Articles & Press Releases

Interested in what happened during the TAT 2019 – International Congress on Targeted Anticancer Therapies?

Read all our news here

Date Title Topic
26 Feb 2019 Study Determines the Types of Cancer in Patients Participating in Phase I Oncology Clinical Trials Anticancer agents & Biologic therapy
26 Feb 2019 Novel Epidrugs May Require Dose Fine Tuning in Phase I Trials Anticancer agents & Biologic therapy
25 Feb 2019 The Lung Immune Prognostic Index Significantly Associates with Outcome Across a Cancer Patient Population Cancer Immunology and Immunotherapy
25 Feb 2019 Analysis Compares the Rates of Access of Adolescents and Young Adults to Clinical Trials of New Drugs Cancer in Special Situations / Population
25 Feb 2019 Rare Cancers a Growing Focus of Early-stage Clinical Trials [ESMO Press Release] Personalised medicine - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
07 Feb 2019 TAT International Congress 2019: the home of phase I oncology [ESMO Media Alert] Personalised medicine - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
24 Jan 2019 Cancer Drug Development Award Given to Geoffrey Shapiro [ESMO Press Release] Personalised medicine - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy